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Abstract
Background: Accurate assessment of probiotics with targeted anti-Salmonella activity requires suitable models
accounting for both, microbe-microbe and host-microbe interactions in gut environments. Here we report the
combination of two original in vitro intestinal models closely mimicking the complex in vivo conditions of the large
intestine. Effluents from continuous in vitro three-stage fermentation colonic models of Salmonella Typhimurium
infection inoculated with immobilized child microbiota and Salmonella were directly applied to confluent mucus-
secreting HT29-MTX cell layers. The effects of Salmonella, addition of two bacteriocinogenic strains, Bifidobacterium
thermophilum RBL67 (thermophilicin B67) and Escherichia coli L1000 (microcin B17), and inulin were tested on
Salmonella growth and interactions with epithelial cell layers. Salmonella adhesion and invasion were investigated
and epithelial integrity assessed by transepithelial electrical resistance (TER) measurements and confocal microscopy
observation. Data from complex effluents were compared with pure Salmonella cultures.
Results: Salmonella in effluents of all reactors of the colonic fermentation model stabilized at mean values of 5.3 ±
0.8 log10 cfu/ml effluent. Invasion of cell-associated Salmonella was up to 50-fold lower in complex reactor samples
compared to pure Salmonella cultures. It further depended on environmental factors, with 0.2 ± 0.1% being
measured with proximal, 0.6 ± 0.2% with transverse and 1.3 ± 0.7% with distal reactor effluents, accompanied by a
similar high decrease of TER across cell monolayers (minus 45%) and disruption of tight junctions. Subsequent
addition of E. coli L1000 stimulated Salmonella growth (6.4 ± 0.6 log10 cfu/ml effluent of all 3 reactors) and further
decreased TER, but led to 10-fold decreased invasion efficiency when tested with distal reactor samples. In contrast,
presence of B. thermophilum RBL67 revealed a protective effect on epithelial integrity compared to previous E. coli
L1000 periods, as reflected by a significant mean increase of TER by 58% in all reactors. Inulin addition enhanced
Salmonella growth and invasion when tested with distal and proximal reactor samples, respectively, but induced a
limited decrease of TER (minus 18%) in all reactors.
Conclusions: Our results highlight the benefits of combining suitable cellular and colonic fermentation models to
assess strain-specific first-level host protection properties of probiotics during Salmonella infection, providing an
efficient system biology tool for preclinical development of new antimicrobials.
Background
The human colon constitutes a protective and nutrient-
rich habitat to trillions of bacteria living in symbiosis
with the host [1]. This complex consortium constantly
competes with exogenous microbes for attachment sites
in the brush border of intestinal epithelial cells, thus
preventing pathogens from entering specific ecological
niches and gut tissues [2]. Pathogens may however over-
come this line of defense, leading to different manifesta-
tions of disease. Infectious gastroenteritis caused by
non-typhoidal strains of Salmonella enterica spp. enter-
ica is an important cause of morbidity and mortality
worldwide [3]. Due to the increasing incidence of anti-
biotic resistant and more virulent serovars [4], the use
of probiotics with specific anti-Salmonella activities is a
prevailing interest. Mechanisms by which probiotics
* Correspondence: christophe.lacroix@ilw.agrl.ethz.ch
† Contributed equally
Laboratory of Food Biotechnology, Institute of Food, Nutrition and Health,
ETH Zürich, Schmelzbergstrasse 7, 8092 Zürich, Switzerland
Zihler et al. BMC Microbiology 2011, 11:264
http://www.biomedcentral.com/1471-2180/11/264
© 2011 Zihler et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.inhibit pathogens include competition for nutritional
substrates and adhesion sites on intestinal epithelial
cells, secretion of antimicrobial substances as well as
toxin inactivation and host immunity stimulation [5].
However, in vivo mechanistic studies of probiotics and
gut microbiota are hindered by ethical considerations,
compliance issues and high costs. A variety of in vitro
gut models have been applied to separately investigate
microbe-microbe and simple microbe-host interactions
[6-8]. Owing to the complexity of the intestinal environ-
ment, suitable models accounting for all intestinal para-
meters including both the gut microbiota and their
substrates and metabolic products as well as the pre-
sence of epithelial intestinal cells, represent an indispen-
sable platform for preclinical probiosis assessment.
To investigate the complex gut microbiota in vitro,
continuous intestinal fermentation models utilizing
immobilized fecal microbiota have been developed for
the controlled long-term cultivation of gut microbiota
with conserved biodiversity [9-11]. Such models allow
independent testing of different experimental treatments
on both gut microbiota composition and metabolic
activity within a single experimental period, using the
same microbiota under controlled environmental condi-
tions, which are designed to simulate the proximal,
transverse and distal colon of healthy and infected sub-
jects [9-14]. More recently, a three-stage in vitro colonic
fermentation model of Salmonella infection in child
colon was used to assess the effects of probiotic and
prebiotic treatments on gut microbial behavior and on
S. Typhimurium infection [15]. The activity of microcin
B17-producing Escherichia coli L1000 wt [16] and bac-
teriocinogenic Bifidobacterium thermophilum RBL67,
both exhibiting strong anti-Salmonella activity in simple
in vitro tests [17,18], as well as the microcin B17-nega-
tive mutant strain MccB17-, were tested in two three-
stage models inoculated with the same fecal inoculum.
When added to the colonic model, E. coli L1000 unex-
pectedly stimulated Salmonella growth in all reactors
independently of the microcin B17-phenotype, partly
due to a low colonization of the strain in the complex
intestinal environment. In contrast, thermophilicin
RBL67-producing Bifidobacterium thermophilum RBL67
revealed high competitiveness and colonized at high
levels but did not reduce Salmonella counts, most likely
a function of the presence of a very high Salmonella
population in the in vitro model prior to probiotic
addition.
Most data available on the mechanistic effects of pro-
biotics on the host are derived from in vitro studies
with intestinal cells [19]. Such models have also been
used to investigate bacterial interactions with the intest-
inal epithelium during enteric infection [20]. Salmonella
pathogenesis, for example, has been studied in pure
cultures using epithelial Caco-2 and HT-29 cell models
[21,22], both of which lack the ability to produce
mucus. The mucus-secreting HT29-MTX cell line how-
ever, represents more accurate physiological conditions
of the gastrointestinal tract for investigating pathogenic
behavior during infection, as the presence of mucus has
been shown to enhance pathogenicity of pathogens such
as Campylobacter jejuni [23]. All interaction studies of
pathogens and probiotics with intestinal cells have been
performed with simple systems of either pure or mixed
cultures. Microbe cell interactions are however different
when tested in the presence of a complex gut micro-
biota [24,25]. Gut metabolites such as SCFAs affect
epithelial cell metabolism, turnover and apoptosis [26]
but may also enhance virulence (e.g. S. Typhimurium),
by inducing an acid tolerance response or increasing
expression of porins [27]. To our knowledge, the effects
of an infected gut microbiota, including its metabolites
and probiotic treatment on intestinal cells has not been
previously reported.
In this study, the mucus-producing HT29-MTX cell
model was used to investigate the interaction of S.
Typhimurium N-15 in presence of a complex intestinal
microbiota and to assess the host-protection properties
of E. coli L1000 and B. thermophilum RBL67 sequen-
tially inoculated in the infection model, as well as the
protective effect of inulin. Effluent samples were pro-
duced in two three-stage continuous colonic models,
mimicking the proximal, transverse and distal colon
regions and inoculated with immobilized child fecal
microbiota and Salmonella, and used to test the effects
of probiotics and inulin on gut microbiota composition
and metabolism, and on Salmonella growth [15]. Efflu-
ents collected from different fermentation periods were
directly applied to HT29-MTX cells to measure Salmo-
nella invasion and monitor changes in cellular integrity
through both measurement of transepithelial electrical
resistance (TER) and confocal microscopy. Data from
complex effluents were compared with pure Salmonella
cultures.
Results
Complex reactor effluents were collected during pseudo-
steady states (last 3 days) of different experimental peri-
ods from two continuous three-stage colonic fermenta-
tion models as indicated in Figure 1 and applied directly
onto confluent mucus-secreting HT29-MTX cells. Tem-
poral and environmental factors affecting bacterial
growth, Salmonella invasion and TER across cell mono-
layers are summarized in Figure 2 and Table 1. TER
across cell monolayers after incubation with simple and
complex fermentation samples are compared in Figure 3
and the effects on epithelial integrity upon effluent
application are shown in Figure 4.
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Page 2 of 13Complex reactor effluents affect TER across HT29-MTX
monolayers
Salmonella were detected neither in reactor effluents
nor after invasion assays in samples obtained at the end
of initial model stabilization periods (Stab). Mean TER
across HT29-MTX monolayers measured after 1-3 h
incubation with effluents from initial model stabilization
periods (Stab) were consistent and similar for all reac-
tors (251 ± 23 Ω cm
2). Furthermore cellular tight junc-
tions were unaffected after 90 min of incubation, as also
demonstrated by confocal microscopy for distal reactor
effluents of F1 (Figure 4A). 24 h post-incubation, a sig-
nificant decrease of TER was recorded (Figure 3). A sig-
nificantly (P < 0.05) higher TER was measured with
transverse and distal effluents compared to proximal
reactor effluents (Table 1), correlating with significantly
increased SCFA concentrations in both R2 (177 ± 6
mM) and R3 (187 ± 20 mM) compared to R1 (141 ± 7
mM, Table 1).
Salmonella invasion is a function of environmental factors
and affects epithelial integrity
Upon infection of the three-stage continuous fermenta-
tion model with S. Typhimurium N-15 beads (Sal, Fig-
ure 2A), Salmonella concentrations in effluents steadily
increased and stabilized at significantly (P < 0.01) higher
levels in proximal (5.8 ± 0.3 log10 cfu/ml) and transverse
(5.6 ± 0.5 log10 cfu/ml) compared to distal colon reac-
tors (4.5 ± 0.7 log10 cfu/ml). Invasion efficiency
expressed as percentage of cell-associated Salmonella,
was significantly higher with effluents of R2 (0.6 ± 0.2%;
P = 0.049) and R3 (1.3 ± 0.7%; P =0 . 0 0 2 )c o m p a r e dt o
R1 (0.2 ± 0.1%) [Sal, Figure 2C]. In contrast, invasion
efficiency of pure cultures of Salmonella in buffered
DMEM was up to 50-fold higher (9.8 ± 2.1%).
Compared to non-infected effluents from initial model
stabilization periods (Stab), a large and significant mean
decrease of TER across HT29-MTX cell monolayers was
measured after 1 h of incubation with effluents of all
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Figure 1 Experimental design of continuous three-stage colonic fermentations. Two three-stage continuous fermentation models (F1 and
F2) simulating (R1) proximal, (R2) transverse and (R3) distal colonic sections were inoculated with the same immobilized child fecal microbiota,
infected with Salmonella beads and operated in parallel for a total of 65 days divided into different experimental periods as described previously
[15]. For this study, reactor effluents collected during the last 3 days of each experimental period were directly applied onto confluent mucus-
secreting HT29-MTX cell layers to detect host-protection properties of different experimental treatments. Data obtained during similar treatments
in models F1 and F2 (highlighted in the same color) were not significantly different and therefore used as repetitions: (Stab) initial system
stabilization periods, (Sal) Salmonella infection periods, (Ecol) E. coli L1000 wt treatments (microcin B17-producing wild-type strain), (Ecol*) E. coli
L1000 MccB17- treatments (microcin B17-negative mutant strain), (Bif) B. thermophilum RBL67 treatments, (Inulin) prebiotic inulin treatment.
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Page 3 of 13reactors from Salmonella infection periods (Sal, Figure
3). Mean TER values did not differ after 1-3 h of incu-
bation (P > 0.05), but significantly decreased after 24 h
of incubation (Figure 3). In contrast, TER measured for
pure cultures of S. Typhimurium N-15 in buffered
DMEM showed a continuous and pronounced decrease
in TER (Figure 3). Compared to initial model stabiliza-
tion periods (Stab), mean TER measured 1-3 h after
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Figure 2 Bacterial growth, Salmonella invasion and TER across HT29-MTX monolayers are affected by experimental and environmental
factors. Values correspond to means ± SD (error bars) calculated for effluents of R1, R2 and R3 in F1 and F2 during the last 3 days of each
experimental period (Figure 1; N = 9 for Bif, N = 6 for Stab, Sal and Ecol, N = 3 for Inulin). (A) Salmonella, E. coli L1000 and B. thermophilum
RBL67 counts measured by plate counts and real-time qPCR analyses, respectively. Counts of major intestinal bacterial groups were presented
previously [15]. (B) Invasion and adhesion ratios, expressed as the percentage of invaded and adhered Salmonella related to the total number
present in effluents. (C) Efficiency of Salmonella to invade HT29-MTX cells, expressed as the percentage of cell-associated Salmonella. (D) TER
across HT29-MTX cell monolayers measured 1-3 h after incubation with reactor effluents, expressed as ratio to values measured with samples of
initial model stabilization periods (Stab). Values reported for subsequent experimental periods and connected with an asterisk are significantly
different with the Tukey-Kramer-HSD test (*P < 0.05; **P < 0.01).
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Page 4 of 13Table 1 TER across HT29-MTX monolayers depends on temporal and environmental factors including SCFAs in reactor
effluents
Experimental period
Stab Sal Ecol I Ecol II Bif Inulin
R1
TER 1-3 h 247 ± 24
a 144 ± 24
bc 143 ± 22
bc 114 ± 14
c 167 ± 34
b 121 ± 13
bc
24 h 127 ± 23
a 69 ± 20
b 55 ± 11
b 36 ± 4
b 130 ± 47
a 65 ± 14
b
SCFAs* (A:P:B) 138 ± 6
a
(54:11:34)
179 ± 6
a
(44:7:50)
R2
TER 1-3 h 266 ± 19
a 135 ± 29
b 144 ± 17
b 96 ± 4
c 158 ± 8
b 142 ± 29
b
24 h 205 ± 34
a 74 ± 17
c 52 ± 4
cd 34 ± 8
d 115 ± 19
b 87 ± 11
bc
SCFAs* (A:P:B) 172 ± 6
b
(54:14:32)
245 ± 6
b
(45:12:43)
R3
TER 1-3 h 240 ± 24
a 124 ± 30
bc 141 ± 16
b 91 ± 6
c 145 ± 8
b 121 ± 30
bc
24 h 190 ± 37
a 75 ± 17
cd 77 ± 13
c 32 ± 11
d 119 ± 30
b 91 ± 25
bc
SCFAs* (A:P:B) 180 ± 13
b
(55:14:31)
234 ± 11
b
(46:11:43)
Mean transepithelial electrical resistance (TER; expressed in Ω cm
2)±SD were measured after incubation of HT29-MTX cell monolayers for 1-3 h (N = 18) and 24
h( N = 6) with effluents retained from (R1) proximal, (R2) transverse and (R3) distal colon reactors of F1 and F2 during the last three days of each experimental
period. Values with different letters in a row of the same reactor are significantly different according to the Tukey-Kramer-HSD test (P < 0.05). *No treatment
effects (except for inulin addition) were detected on total short chain fatty acid (SCFA) concentrations (expressed in mM). Mean SCFA concentrations±SD and
(A) acetate: (P) propionate: (B) butyrate ratios measured during the last three days of non-inulin (N = 33) and inulin (N = 3) periods are therefore presented. Values
with different letters in the same column of different reactors are significantly different with the Tukey-Kramer-HSD test (P < 0.05). (Stab) initial system
stabilization periods, (Sal) Salmonella infection periods, (Ecol) E. coli L1000 treatments, (Bif) B. thermophilum RBL67 treatments, (Inulin) prebiotic inulin treatment.
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Figure 3 TER across HT29-MTX monolayers upon application of infected simple and complex fermentation samples. Values correspond
to means ± SD (error bars) calculated 1, 2, 3 and 24 h after incubation with complex fermentation effluents of all three reactors from models F1
and F2 obtained during (Stab) initial model stabilization and (Sal) Salmonella infection periods (N = 6), compared to values measured after
incubation with (–x–) S. Typhimurium N-15 in DMEM alone.
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Page 5 of 13incubation with effluents of all reactors from Salmonella
infection periods (Sal) were significantly lower (P <
0.0001, Table 1), with a mean decrease of 40 ± 4% (Fig-
ure 2D). This effect on cell integrity was confirmed by
confocal microscopy analysis which demonstrated highly
disrupted tight junctions after Salmonella infection for
distal reactor (R3) effluents of F1 (Figure 4B) compared
to initial model stabilization periods (Figure 4A).
E. coli L1000 stimulates Salmonella growth yet reduces
invasion in the distal colon region
E. coli L1000 established itself in the three-stage model
at low levels with slightly but non-significantly higher
n u m b e r sm e a s u r e di nR 3( 4 . 9±0 . 9l o g 10 MCN/ml)
compared to R1 (4.5 ± 0.6 log10 MCN/ml) and R2 (4.3
± 0.6 log10 MCN/ml; Figure 2A).
As shown previously [15], the addition of E. coli L1000
beads to the intestinal fermentation model enhanced
Salmonella growth in all colon reactors compared to
initial Salmonella infection periods (Sal; Figure 2A).
However, significantly lower Salmonella invasion ratios
were measured with transverse and distal reactor efflu-
ents (Figure 2B) in comparison with initial Salmonella
stabilization periods (Sal). Concomitantly, Salmonella
adhesion ratios remained stable in R3 (Figure 2B), how-
ever the efficiency of cell-associated Salmonella to
invade HT29-MTX cells (Figure 2C) decreased signifi-
cantly. The second addition of E. coli L1000 (Ecol II)
A B
C D
20 μm 20 μm
20 μm 20 μm
5 μm
5 μm 5 μm
Figure 4 HT29-MTX monolayer integrity in complex colonic environments is affected by Salmonella infection and probiotic
treatments. Tight junctions (in red) and nuclei (in blue) of HT29-MTX cells were stained with phalloidin and DAPI, respectively, after incubation
for 90 min with distal reactor effluents of F1 retained at the end of (A, Stab) initial model stabilization, (B, Sal) Salmonella infection, (C, Ecol II) E.
coli L1000 and (D, Bif I) B. thermophilum RBL67 periods. Tight junctions were highly disrupted after incubation with effluents from Salmonella
infection (Sal) compared to initial model stabilization periods (Stab).
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Page 6 of 13had no further effects on Salmonella adhesion and inva-
sion ratios in R1 and R3. However, a significantly
enhanced (P = 0.0004) Salmonella invasion ratio was
measured with transverse reactor effluents (Figure 2B)
compared to the first E. coli L1000 period (Ecol I),
which was accompanied by a significant increase in
invasion efficiency (Figure 2C).
Similar mean TER values were measured with efflu-
ents from first E. coli L1000 (Ecol I) and Salmonella
colonization (Sal) periods for all reactors (Table 1, Fig-
ure 2D), despite significantly higher Salmonella counts
(P < 0.01) after the addition of E. coli L1000 (Figure
2A). TER significantly (P > 0.05) decreased by 19% and
26% with transverse and distal reactor effluents respec-
tively (Figure 2D) after the second addition of E. coli
L1000 (Ecol II) compared to the previous period (Ecol I)
while Salmonella counts did not change for the two E.
coli periods (Figure 2A).
B. thermophilum RBL67 exerts a protective effect on
epithelial integrity in highly infected environments
B. thermophilum RBL67 colonized all reactors of the
two three-stage fermentation models, reaching high
counts of 6.8 ± 0.5, 6.4 ± 0.4 and 6.5 ± 0.3 log10 MCN/
ml in R1, R2 and R3, respectively (Bif; Figure 2A). Addi-
tion of B. thermophilum RBL67 beads increased Salmo-
nella counts in R1 compared to the previous E. coli
L1000 treatment (Ecol II, Figure 2C). However, Salmo-
nella invasion efficiency did not change for any of the
reactors and the invasion ratio measured with transverse
reactor samples significantly decreased during Bif com-
pared to Ecol II periods (Figure 2B).
B. thermophilum RBL67 addition (Bif) significantly (P
= 0.0001) increased the mean TER measured across
HT29-MTX cell monolayers applied with effluents of all
reactors by 58 ± 17% compared to previous E. coli
L1000 period (Ecol II, Figure 2D). Mean TER measured
after 24 h of incubation with effluents from proximal
reactors (130 ± 47 Ω cm
2)w a ss i m i l a r( P > 0.05) to
initial model stabilization periods (Stab) before Salmo-
nella infection (127 ± 23 Ω cm
2; Table 1). Confocal
microscopy analysis revealed high integrity of intracellu-
lar junctions upon application of distal colon reactor
effluents of F1 after addition of B. thermophilum RBL67
(Figure 4D) despite high Salmonella counts (6.4 ± 0.6
log10 cfu/ml).
Inulin stimulates B. thermophilum RBL67 growth but
increases Salmonella invasion in proximal colon
environments
Addition of inulin induced a significant (P = 0.022)
increase in Salmonella counts (Figure 2A) in R3 com-
pared to previous B. thermophilum RBL67 periods (Bif).
Furthermore a pronounced enhancement of B.
thermophilum RBL67 growth (Figure 2A) and an
increase in SCFA concentrations and butyrate ratios
(Table 1) occurred in all reactors. Inulin supplementa-
tion in R1 was accompanied by a significant (P =0 . 0 2 4 )
increase in the efficiency of Salmonella to invade HT29-
MTX cells compared to the previous B. thermophilum
RBL67 period (Bif). This effect was not significant for
transverse and distal reactor samples. Inulin treatment
also induced a 25%-decrease (P = 0.088) in TER after 1-
3 h of incubation for effluents of R1 compared to the
previous B. thermophilum RBL67 periods (Table 1),
while a similar but less pronounced tendency was
observed for transverse and distal reactors.
Discussion
Accurate assessment of probiotic-mediated anti-Salmo-
nella activities is complicated by the fact that mechan-
isms involved in enteric protection are the function of
many probiotic features. Various interactions take place
in complex gut environments, including competition for
substrates, direct antagonism by the production of inhi-
bitory substances (e.g. SCFA or bacteriocins), competi-
tive exclusion, and potentially host-mediated effects
such as improved barrier function and altered immune
response [5,28,29]. It is therefore crucial to consider
microbe-microbe as well as host-microbe interactions
for the development of probiotics with targeted efficacy.
Beyond animal in vivo models, combinatorial in vitro
systems using both gut fermentation and cell models are
an integral component in system biology approaches
aimed at developing new probiotics [6]. For example,
the dynamic TNO-gastrointestinal system (TIM-1) of
the human small intestine combined with the Caco-2
cell model was used to investigate the digestive stability
and intestinal absorption of lycopene and a-tocopherol
[7] Furthermore, adhesion to and cytokine expression of
Caco-2 cells was assessed using bacterial cultures,
including the probiotic strain Bifidobacterium longum
DD2004, obtained from a three-stage continuous-culture
system (CCS) simulating the proximal and distal large
intestine [8]. Results clearly indicate that application of
fermentation effluents to intestinal cells represents a
valuable platform for assessing epithelial responses as a
function of in vitro fermentative processes and microbial
interactions. In this study, a three-stage continuous
intestinal fermentation model closely mimicking condi-
tions in the proximal, transverse and distal colon regions
and inoculated with immobilized child feces was used to
generate a complex microbiota. For the first time, we
report the effects of Salmonella in a complex gut micro-
biota containing metabolites and grown under environ-
mental conditions of the different sections of the colon,
on mucus-secreting intestinal HT29-MTX cells. This
combined model approach was used to assess host-
Zihler et al. BMC Microbiology 2011, 11:264
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Page 7 of 13protecting, anti-Salmonella activities of probiotic and
prebiotic combinations.
Mean invasion efficiencies of S. Typhimurium N-15
into HT29-MTX cells measured in colonic effluents
were up to 50-fold lower compared to values measured
in simple experimental conditions of a single Salmonella
strain in DMEM, reflecting different microbe cell inter-
actions in simple systems compared to environments
with a complex gut microbiota [24]. Bacterial interac-
tions occurring at the brush-border of HT29-MTX cells
may enhance barrier function and diminish Salmonella
invasion capacity, through the presence of a complex
host microbiota, specific metabolites, as well as competi-
tion for adhesion sites. SCFAs at physiological concen-
trations are known to induce a concentration-
dependent, reversible change in cellular permeability in
vitro [25,30]. A higher concentration of total SCFAs in
fecal water of adults applied to Caco-2 cells was shown
to be associated with an increase in TER in comparison
to fecal water obtained from elderly subjects containing
lower SCFA concentrations which negatively affected
epithelial barrier function [31]. Our results obtained
with effluents sampled at the end of model stabilization
periods (Stab) were in accordance with these findings.
Indeed, a generally higher TER across HT29-MTX cell
monolayers was measured after 24 h of incubation for
transverse and distal reactor samples with a high con-
centration of SCFAs accumulating in the in vitro model
due to the lack of absorption, compared to samples
from the proximal reactor. In general, lower TER values
were measured during all experimental periods and for
all reactors upon effluent exposure for 24 h compared
to 1-3 h. As reactor effluents contain a dense and active
microbiota, bacterial fermentation and pH reduction can
occur during intestinal cell incubation which can nega-
tively affect cell viability thus epithelial integrity [23].
Salmonella invasion is influenced by environmental
factors such as pH or SCFA concentrations. Upon infec-
tion Salmonella invasion was generally higher in distal
reactors (pH 6.7) compared to proximal (pH 5.7) and
transverse (pH 6.2) reactors and inversely related to
SCFA concentrations. These results are consistent with
findings of Durant et al. [32], demonstrating that Salmo-
nella entry into HEp-2 cells was higher at pH 7 com-
pared to pH 6 in the presence of 80 mM acetate, 40
mM propionate and 20 mM butyrate. A lower percen-
tage of cell-association and invasion was observed as the
concentration of each SCFA increased at pH 6 but not
at pH 7 [32]. Salmonella invasion into intestinal cells is
known to be associated with a rapid disruption of
epithelial integrity caused by structural modifications of
intercellular junctions that can be assessed by TER mea-
surements [8,33,34]. In this study, we effectively demon-
strated that effluents obtained from three-stage in vitro
colonic fermentation models of Salmonella infection
and applied directly on confluent and fully differentiated
HT29-MTX cells induces a large and significant
decrease of TER after 1 h of incubation, compared to
non-infected effluents (Figure 3). Visualization of tight
junctions by phalloidin staining revealed that intracellu-
lar junctions of HT29-MTX cells were not affected by
the gut microbiota produced during initial model stabili-
zation (Stab, Figure 4A) but were highly disrupted in the
presence of Salmonella (Sal, Figure 4B). This is in accor-
dance with results published by Jepson et al.[ 3 5 ]w h e r e
incubation of MDCK monolayers with S. typhimurium
SL1344 for 60 min was accompanied by a disruption of
intracellular junctions.
Addition of E. coli L1000 enhanced Salmonella growth
in all reactors although the efficiency of Salmonella in
invading HT29-MTX cells significantly decreased in dis-
tal reactor (R3) samples. After the addition of B. thermo-
philum RBL67, the invasion efficiency of Salmonella
decreased most in proximal reactors (R1), despite higher
Salmonella counts compared to previous Ecol II periods.
These results may reflect the influence of environmental
requirements for optimal growth of the tested probio-
tics. B. thermophilum RBL67 is acid tolerant and a com-
petitive bacteriocinogenic bacteria [15,18], a trait likely
advantageous for competing with other members of the
bacterial ecosystem present in proximal colon reactors
at pH 5.7. Indeed, B. thermophilum RBL67 best colo-
nized and reduced Salmonella invasion into HT29-MTX
cells at pH 5.7 with proximal reactor samples, while E.
coli L1000 was more competitive at pH 6.6 in distal
colon reactors.
T h ep r e s e n c eo fE. coli L1000 in the fermentation
model not only enhanced Salmonella growth but also
induced further disruption of epithelial integrity, a find-
ing which was unexpected. A similar decrease in TER
was observed for T84 cells when preventively incubated
with E. coli Nissle 1917 before addition of S. dublin
[36]. In contrast, TER values and epithelial integrity
after B. thermophilum RBL67 addition were significantly
enhanced in all reactors of both models although Salmo-
nella counts were very high. Several studies reported
that live Gram-positive probiotics are able to enhance
monolayer barrier function and protect cultured epithe-
lial cells from the effects of infection with invasive
pathogens. Preventive treatments with Lactobacillus
acidophilus and Streptococcus thermophilus, for example,
were shown to prevent the enteroinvasive Escherichia
coli (EIEC)-induced decrease in TER of HT29/cl 19A
cell monolayers [37]. Bifidobacterium infantis and Bifi-
dobacterium breve of the probiotic cocktail VSL#3, were
shown to improve epithelial integrity of T84 cells and
resistance to Salmonella invasion [38]. It was suggested
that Gram-positive and Gram-negative probiotics use
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intestinal epithelium and to mediate protection against
Salmonella [36]. Indeed, the ability of E. coli Nissle 1917
and the probiotic mixture VSL#3 to diminish Salmo-
nella dublin-induced death of T84 cells was related to
the induction of IL-8 secretion by the Gram-negative
probiotic, while the Gram-positive probiotic mixture
was shown to prevent pathogen-induced decrease in
TER and stabilize tight junctions.
Among SCFAs, a special function is assigned to buty-
rate. In the gut lumen, butyrate is used by epithelial
cells as an energy source whereas in tumor cells (e.g.
HT29-MTX) butyrate reduces survival by inducing
apoptosis and inhibiting proliferation [19,39,40] with
concentrations ≥ 8 mM being shown to reduce TER of
Caco-2 cells [41]. A similar effect was observed in this
study. Inulin induced a strong bifidogenic effect and a
shift in SCFA ratios, with a strong increase in butyrate
concentrations (Table 1), accompanied by a decrease in
TER.
Conclusions
Our results highlight the benefits of combining suitable
cellular and colonic fermentation models to evaluate
host protection activity of probiotics during Salmonella
infection in the presence of commensal gut organisms,
providing efficient tools for mechanistic studies in vitro
which may enhance preclinical development of new
antimicrobials. The application of a complex microbiota
produced in an in vitro fermentation model to HT29-
MTX cells revealed that optimal environmental condi-
tions and the impact on Salmonella infectivity and
intestinal epithelial integrity differed for both probiotic
strains tested. E. coli L1000 remained at low levels but
preferentially colonized the simulated distal colon and
also stimulated Salmonella growth which was accompa-
nied by a significant disruption of epithelial integrity. In
contrast, B. thermophilum RBL67 was very competitive
and established itself at high levels preferentially in
proximal colon reactors. Its presence induced a high
increase in TER after 24 h of incubation in all reactors
and both models to levels similar to that measured
before Salmonella addition. Additional studies examin-
ing cellular immune responses, including utilizing fecal
material from other donors to account for differences in
individual gut ecosystems, are necessary in further eluci-
dating the mechanisms of B. thermophilum RBL67 and
E. coli L1000 for treatment of Salmonella infections
prior to large-scale and costly in vivo trials.
Methods
Bacterial strains
Salmonella enterica spp. enterica serovar Typhimurium
N-15 (S. Typhimurium N-15) was isolated in 2007 from
an infected person in Switzerland and obtained from the
National Center for Enteropathogenic Bacteria (NENT,
Luzern, Switzerland). It was routinely cultivated in tryp-
tic soy broth (TSB, Difco, Basel Switzerland) at 37°C for
18 h.
E. coli L1000 wt, producing microcin B17 [16], was
kindly provided by Hans-Dieter Grimmecke (Laves-Arz-
neimittel GmbH, Schötz, Switzerland). A mutant strain
lacking microcin B17-phenotype (E. coli L1000 MccB17-
) was also used [15]. B. thermophilum RBL67, initially
isolated from baby feces [42], was obtained from our
culture collection.
Intestinal in vitro colonic fermentations
Intestinal colonic fermentations were performed as pre-
viously reported [15]. In brief, two three-stage continu-
ous in vitro fermentation models (F1 and F2) inoculated
with the same immobilized child fecal microbiota were
infected with S. Typhimurium N-15. These models were
operated in parallel for 65 days to test and compare the
effects of treatments with probiotic E. coli L1000 wt and
MccB17-, followed by B. thermophilum RBL67, and pre-
biotic inulin, on gut microbiota composition, activity,
probiotic growth and Salmonella colonization [15]. Spe-
cific retention times (RT) and pH were applied to the
three reactors of each model corresponding to the phy-
siological conditions in child proximal (R1), transverse
(R2) and distal (R3) colons: RT = 5 h and pH 5.7 for
R1, RT = 10 h and pH 6.2 for R2, and RT = 10 h and
pH 6.6 for R3, respectively [43,44].
Continuous fermentations were divided into six conse-
cutive experimental periods illustrated in Figure 1 and
presented in detail by Zihler et al. [15]. Briefly, the first
model F1 used to test E. coli L1000 wt, included the fol-
lowing conditions: (1) system stabilization [Stab, 10
days], (2) S. Typhimurium N-15 beads addition to R1 to
induce Salmonella infection [Sal, 9 days], (3) first E. coli
L1000 wt beads addition to R1 [Ecol I, 14 days], (4) sec-
ond E. coli L1000 wt beads addition to R3 [Ecol II, 8
days], (5) first B. thermophilum RBL67 beads addition to
R 1[ B i f ,1 1d a y s ] ,a n d( 6 )s e c o n dB. thermophilum
RBL67 beads addition to R1 [Bif II, 10 days]. In the sec-
ond model F2 E. coli L1000 wt was replaced by E. coli
L1000 MccB17- to assess the effect of microcin B17
phenotype. Similar periods as F1 were tested except for
the last period (6) during which prebiotic inulin was
tested [Inulin, 10 days].
Effluents (13 ml) were collected daily from each reac-
tor of the two models and processed within 1 h for the
enumeration of S. Typhimurium N-15 (selective plating),
quantification of main bacterial populations (real-time
qPCR analyses), and metabolic analysis [15]. Fresh efflu-
ents were also directly applied on intestinal HT29-MTX
cells.
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Salmonella enumeration by plate counts
Salmonella viable cell counts were measured during the
last 3 days of each experimental period corresponding
to pseudo-steady-state conditions. Effluent samples were
serially diluted 10-fold in peptone water (0.1%, pH 7.0)
and plated in duplicate on CHROMAgar™Salmonella
(Becton Dickinson AG, Allschwil, Switzerland). Plates
were incubated at 37°C for 48 h.
E. coli L1000 and B. thermophilum RBL67 enumeration by
real-time qPCR analysis
E. coli L1000 and B. thermophilum RBL67 concentra-
tions in reactor effluents were estimated by real-time
qPCR analysis as described before [15]. Mean copy
numbers (MCN/ml) were calculated for the last 3 days
of each experimental period of F1 and F2.
Metabolite analysis
Short-chain fatty acids [SCFA: acetate (A), propionate
(P) and butyrate (B)] concentrations in effluent samples
were determined in duplicate by high-performance
liquid chromatography (HPLC) analysis [12].
Cell cultures
The human mucus-secreting intestinal colon cancer cell
line HT29-MTX [45], obtained after long-term treatment
of human carcinoma HT-29 cells with the anti-cancer
drug methotrexate [46], was kindly provided by Dr. Thécla
Lesuffleur (INSERM, Lille, France). Cells were routinely
maintained at 37°C in a humidified incubator (10% CO2)
in complete Dulbecco’s Modified Eagle medium Glutamax
(DMEM; Invitrogen AG, Basel, Switzerland) supplemented
with 10% (V/V) fetal bovine serum (FBS; Invitrogen AG)
and 1% (V/V) antibiotics (10’000 U/ml penicillin + 10’000
μg/ml streptomycin; Invitrogen AG). For invasion assays,
cells were seeded in 24-well tissue culture plates (2 cm
2
well
-1; Bioswisstec AG, Schaffhausen, Switzerland) at a
concentration of 4 × 10
4 cells per well and cultivated for
21 days to reach complete confluence and differentiation.
The medium was replaced every 2 days and cell viability
was determined by tryptan blue staining (0.1% (V/V) in 10
mM phosphate buffered saline (PBS), pH 7.3). DMEM
without antibiotics was used for the last medium change
before using the cells for invasion assays.
For transepithelial electrical resistance (TER) measure-
ments, HT29-MTX cells were seeded in cell culture
inserts with a 0.45 μm filter membrane and a 0.7 cm
2
surface area (24-well culture plate, Millipore AG, Zug,
Switzerland) at a concentration of 2.3 × 10
5 cells per
insert and cultivated as described above.
Invasion assays
A gentamicin-based assay, as described by Steele-Morti-
mer et al. (2008) but with some modifications, was
performed to determine the capacity of Salmonella pre-
sent in reactor effluents to invade HT29-MTX cells.
Briefly, 1 ml effluents obtained during the last 3 days of
each fermentation period from proximal (R1), transverse
(R2) and distal (R3) colon reactors were applied directly
in duplicate on cell layers of three consecutive passages
and incubated at 37°C for 90 min. To kill non-invading
bacteria, cell layers were washed twice with 250 μlP B S
before adding 250 μl DMEM supplemented with 150
μg/ml gentamicin (Sigma-Aldrich Chemie GmbH,
Buchs, Switzerland) per well followed by an additional
incubation period for 60 min at 37°C. After a further
washing step with PBS, 250 μl Trypsin-EDTA (1X, Invi-
trogen) were added followed by another incubation for
10 min. Finally, cells were disrupted by adding 250 μl
0.1% (V/V) Triton X-100 (Sigma) per well and incubat-
ing for 10 min before samples were collected for enu-
meration of invaded Salmonella. The same protocol but
without gentamicin treatments was used for the deter-
mination of cell-associated Salmonella (accounting for
both invasive and adherent bacteria). The number of
adhered Salmonella was then calculated from the differ-
ence of cell-associated to invaded bacteria. Adhesion
and invasion ratios were expressed as the percentage of
adhered and invaded bacteria, respectively, related to the
total number of Salmonella present in effluents. Inva-
sion efficiency measured during different probiotic and
prebiotic treatments was expressed as the percentage of
invaded bacteria related to the number of cell-associated
Salmonella.
The same protocol was used to measure the invasion
efficiency of S. Typhimurium N-15 in pure culture when
applied in artificial DMEM medium. Therefore, the pel-
let of an overnight culture of Salmonella obtained by
centrifugation (8000 g, 5 min) was diluted in DMEM to
reach a concentration of 1.0 × 10
7 cfu/ml. 125 μlo ft h i s
bacterial suspension was added in duplicate to cell
monolayers that corresponded to a Salmonella concen-
tration (1.3 × 10
6 cfu/ml) measured in effluents from
the two models during Sal periods.
Transepithelial electrical resistance (TER) measurements
TER measurements were performed to estimate the
degree of cell monolayer’s integrity loss that occurs dur-
ing Salmonella infection due to disruption of tight junc-
tions [33]. To measure the epithelial integrity of HT29-
MTX cells, 400 μl of effluent was applied directly to the
apical compartment of PBS-washed HT29-MTX cell
culture inserts that were prepared as previously
described. TER measurements were performed before
effluent application and after 1, 2, 3 and 24 h of incuba-
tion at 37°C. The resistance of cell layers was calculated
by subtracting the intrinsic resistance of the filter insert
alone from the total measured resistance (filter insert
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cm
2 surface area. The same protocol was used to mea-
sure the influence of S. Typhimurium N-15 on TER of
HT29-MTX cells in artificial DMEM medium as pre-
sented before.
Microscopic analysis of tight junctions
To visualize the effects of Salmonella infection on cell
monolayer integrity before and during probiotic treat-
ments, tight junctions and the nucleus of confluent
HT29-MTX cells were fluorescently stained according
to previous studies [35,47].
Briefly, HT29-MTX cells were seeded at 9.6 × 10
4
cells/ml on a coverslip in a 6-well tissue culture plate
and cultured to confluence before incubation with 1 ml
of distal colon reactor (R3) effluents from the last day of
different treatment periods of F1. DMEM-high glucose
without Phenol red (Invitrogen AG, Basel, Switzerland)
supplemented with 10% (V/V) fetal bovine serum (FBS;
Invitrogen AG) and without antibiotics was used for the
last medium change before invasion assays. After incu-
bation of 1 ml effluent for 90 min, cells were washed
thrice with PBS and fixed overnight in 1 ml per well of
a chilled 4% (V/V) formaldehyde (Sigma-Aldrich Chemie
GmbH, Buchs, Switzerland) in PBS solution. After a sec-
ond washing step (3 times with PBS), cells were permea-
bilized by treating them with 200 μlo f0 . 1 %T r i t o nX -
100 in PBS for 3 min at room temperature. After a third
washing step (3 times with PBS), cells were treated with
1 ml of 3% (V/V) albumin bovine serum (BSA, Sigma-
Aldrich Chemie GmbH) in PBS to prevent non-specific
binding of fluorescent dyes. Tight junctions were stained
for 40 min with 1 ml of a 1:200 PBS-diluted stock solu-
tion (0.1 mg/ml) of phalloidin-tetramethylrhodamine B
isothiocyanate (phalloidin-TRITC, Sigma-Aldrich Che-
mie GmbH) in methanol, while nuclei were stained for
3 min with 1 ml of a 1:100 PBS-diluted stock solution
(5 mg/ml) of 4’, 6-diamidino-2-phenylindole (DAPI,
Sigma-Aldrich Chemie GmbH) in ultrapure water. After
a last washing step, coverslips were mounted inverted
on a coverglas by applying one drop of the embedding
media Glycergel (DakoCytomation; Glostrup, Denmark).
Microscopic analyses were performed with a confocal
laser scanning microscope (SP 2, Leica Microsystems,
Mannheim, Germany). Different series of images were
obtained and stacked by using the Imaris 7 software
(Bitplane AG, Zürich, Switzerland).
Statistical analysis
All statistical analyses were performed using JMP 8.0 for
Windows (SAS Institute Inc., Cary, NC, USA). Bacterial
counts as well as adhesion and invasion data were
log10-transformed to stabilize the variance and normal-
ize residuals values for variance homogeneity.
A one-way analysis of variance (ANOVA) was per-
formed to compare the effects of two consecutive treat-
ments on mean Salmonella counts, adhesion and
invasion capacities, as well as percentage changes in
invasion and adhesion ratios, invasion efficiencies and
transepithelial electrical resistance (TER). Measurements
during the last 3 days of each fermentation period cor-
responding to a pseudo-steady-state were used as repeti-
tion. Salmonella counts, invasion and adhesion ratios, as
well as invasion efficiency and TER measured during the
last 3 days of each experimental period were not signifi-
cantly different for F1 and F2, which were inoculated
with the same child fecal microbiota immobilized in
beads. Therefore, data obtained during system stabiliza-
tion (Stab), Salmonella colonization (Sal) as well as E.
coli L1000 (Ecol) and B. thermophilum RBL67 (Bif)
treatment periods of F1 and F2 were used as indepen-
dent replicates. TER data measured after 1, 2 and 3 h of
incubation were not significantly different (P > 0.05).
Therefore, mean TER values for the three incubation
times were reported. Treatment means were compared
using the Tukey-Kramer-HSD test with probability
levels of P < 0.05 and P < 0.01.
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